Organogenesis Holdings (ORGO) Operating Income (2016 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Operating Income of -$68.9 million for Q1 2026, down 157.57% year-over-year from $119.7 million in Q1 2025, and down 208.85% quarter-over-quarter from $63.3 million in Q4 2025.
Organogenesis Holdings (ORGO) Operating Income (2016 - 2026) Analysis & Trends
Organogenesis Holdings' Operating Income history runs 11 years deep, the most recent figure standing at -$68.9 million for Q1 2026.
- In Q1 2026, Operating Income fell 157.57% year-over-year to -$68.9 million; the TTM figure through Mar 2026 stood at $2.5 million (up 110.54% YoY), while the FY2025 annual figure was $44.7 million, up 3583.55% from the prior year.
- Operating Income for Q1 2026 stood at -$68.9 million, down from $63.3 million in the prior quarter.
- The five-year high for Operating Income was $63.3 million in Q4 2025, with the low at -$68.9 million in Q1 2026.
- The 5-year median for Operating Income is $1.8 million (2022), against an average of $549941.2.
- The sharpest annual moves came in 2023 and 2024: Operating Income plunged 3025.78% in 2023, then soared 905.28% in 2024.
- Organogenesis Holdings' Operating Income stood at $8.7 million in 2022, then sank by 114.56% to -$1.3 million in 2023, then jumped by 905.28% to $10.2 million in 2024, then surged by 519.33% to $63.3 million in 2025, then slumped by 208.85% to -$68.9 million in 2026.
- Business Quant data shows ORGO's Operating Income at -$68.9 million in Q1 2026, $63.3 million in Q4 2025, and $20.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | -50.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -50.99 Mn |
| Mar 31, 2026 | -68.89 Mn |
| Dec 31, 2025 | 63.29 Mn |
| Sep 30, 2025 | 20.73 Mn |
| Jun 30, 2025 | -12.58 Mn |
| Mar 31, 2025 | -26.75 Mn |
| Dec 31, 2024 | 10.22 Mn |
| Sep 30, 2024 | 6.24 Mn |
| Jun 30, 2024 | -13.89 Mn |
| Mar 31, 2024 | -3.85 Mn |
| Dec 31, 2023 | -1.27 Mn |
| Sep 30, 2023 | 8.05 Mn |
| Jun 30, 2023 | 9.75 Mn |
| Mar 31, 2023 | -4.00 Mn |
| Dec 31, 2022 | 8.72 Mn |
| Sep 30, 2022 | 1.78 Mn |
| Jun 30, 2022 | 11.94 Mn |
| Mar 31, 2022 | -128,000.00 |
| Dec 31, 2021 | 19.75 Mn |
| Sep 30, 2021 | 16.26 Mn |